Technical Analysis for ARCH - Arch Biopartners Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Up 3 Days in a Row | Strength | 0.00% | |
| Shooting Star Candlestick | Bearish | 2.04% | |
| Lizard Bearish | Bearish Day Trade Setup | 2.04% | |
| Crossed Above 20 DMA | Bullish | 2.04% | |
| Narrow Range Bar | Range Contraction | 2.04% | |
| Doji - Bearish? | Reversal | 2.04% | |
| Gapped Up | Strength | 2.04% | |
| Lower Bollinger Band Touch | Weakness | 3.45% | |
| Lower Bollinger Band Touch | Weakness | 6.38% | |
| Narrow Range Bar | Range Contraction | 3.45% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 2 days ago |
| Up 1% | 2 days ago |
| Up 2% | 3 days ago |
| Rose Above Previous Day's High | 3 days ago |
| Rose Above 20 DMA | 3 days ago |
Get a Trading Assistant
- Earnings date: 2024-08-27
Arch Biopartners Inc Description
Arch Biopartners Inc. is a portfolio-based biotechnology company. The Company is focused on the development of technologies that make a medical or commercial impact. Its technology platforms include AB569, MetaBlok, Arch Inflammation, Borg and MetaMx. AB569 is a drug candidate for treating antibiotic resistant bacterial infections, primarily in the lungs and urinary tract. MetaBlok is a drug candidate targeting sepsis, cancer metastasis and inflammation based diseases. Arch Inflammation is a treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. Arch Inflammation is focused on developing anti-inflammatory small molecules that target proteins in the innate immune system. Borg is a peptide-solid surface Interface for binding of peptides to solid metal and plastic surfaces to inhibit biofilm formation. MetaMx are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. The Company has not generated any revenues.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Metal Health Medicine Biotechnology Drug Disease Cancer Diseases Plastic Bacteria Infection Tumor Immunology Immune System Peptide Proteins Antibiotic Biofilm Inflammation Peptides Brain Brain Tumor Chronic Kidney Infections Technology Platforms
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.56 |
| 52 Week Low | 0.97 |
| Average Volume | 14,018 |
| 200-Day Moving Average | 1.663 |
| 50-Day Moving Average | 1.537 |
| 20-Day Moving Average | 1.463 |
| 10-Day Moving Average | 1.445 |
| Average True Range | 0.054 |
| RSI (14) | 52.61 |
| ADX | 54.48 |
| +DI | 10.856 |
| -DI | 29.168 |
| Chandelier Exit (Long, 3 ATRs) | 1.387 |
| Chandelier Exit (Short, 3 ATRs) | 1.523 |
| Upper Bollinger Bands | 1.519 |
| Lower Bollinger Band | 1.407 |
| Percent B (%b) | 0.83 |
| BandWidth | 7.683 |
| MACD Line | -0.022 |
| MACD Signal Line | -0.031 |
| MACD Histogram | 0.009 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.545 | ||||
| Resistance 3 (R3) | 1.540 | 1.520 | 1.538 | ||
| Resistance 2 (R2) | 1.520 | 1.509 | 1.523 | 1.535 | |
| Resistance 1 (R1) | 1.510 | 1.501 | 1.515 | 1.515 | 1.532 |
| Pivot Point | 1.490 | 1.490 | 1.493 | 1.493 | 1.490 |
| Support 1 (S1) | 1.480 | 1.479 | 1.485 | 1.485 | 1.468 |
| Support 2 (S2) | 1.460 | 1.471 | 1.463 | 1.465 | |
| Support 3 (S3) | 1.450 | 1.460 | 1.463 | ||
| Support 4 (S4) | 1.455 |
